A secondary school in Bujumbura, Burundi, reported a sharp increase in cases of respiratory illness in January 2026. Health officials investigating the sudden surge in sickness among the student population conducted diagnostic testing to determine the cause of the outbreak. Symptomatic students tested negative for SARS-CoV-2, ruling out the presence of that specific virus. Medical teams continue to monitor the facility as they work to identify the precise pathogen responsible for the infections. The school remains under observation while authorities evaluate the health status of the affected pupils.
Genomic Analysis of Samples
Researchers analyzed eight nasopharyngeal samples collected from students at the Bujumbura school to identify the underlying pathogen. The laboratory team utilized the Illumina Viral Surveillance Panel version 2 to process these specimens. All testing took place on an iSeq 100 platform to ensure accurate diagnostic results.
Laboratory findings confirmed the presence of the Influenza A virus in seven of the eight samples analyzed. This data provides the primary clinical confirmation of the outbreak's origin following the initial wave of respiratory illness reported in January 2026. Authorities currently hold these results as the definitive explanation for the surge in sickness observed among the student population.
Subclade K Viral Characteristics
Four samples yielded near-complete genomes identified as Influenza A(H3N2) subclade K. These sequences provided the foundational data for researchers tasked with understanding the specific characteristics of the virus circulating within the student population.
Phylogenetic analysis suggested the presence of at least two distinct viral lineages of H3N2 subclade K during the outbreak. Scientists observed these genetic variations after comparing the collected samples against established sequences uploaded to GISAID. This divergence indicates that multiple transmission events may have contributed to the rapid spread of the illness within the school facility.
No resistance-associated markers for neuraminidase inhibitors were detected in the samples. Laboratory teams confirmed that the identified Influenza A(H3N2) subclade K strains remain susceptible to standard antiviral medications. These findings assist health authorities in Burundi as they finalize clinical treatment protocols for the affected students. Medical personnel in Bujumbura now possess clear data indicating that current pharmaceutical interventions should remain effective against the specific viral strains identified during the investigation.